Touchlight is “industrializing” plasmid synthesis to support the development of DNA-based genetic medicines. Based in London, Touchlight has developed a novel, synthetic DNA vector known as “doggybone DNA” or dbDNA™—a minimal, linear, covalently closed structure. This enzymatically synthesized DNA can incorporate a gene of interest up to 20 kilobases (kb), making it very flexible to support a range of genetic medicines . . .

Get GEN Edge Today!

See More on the Edge

Continue reading this article and more
with a GEN Edge subscription

Start Your 30-Day Free Trial Now

Log In Join GEN Edge